Marktbericht für Tiermedizin im Nahen Osten und Afrika - Branchentrends und Prognose bis 2032

Middle East And Africa Veterinary Medicine Market

Marktgröße in Milliarden USD

CAGR : 6.50 %

USD 2.86 Billion USD 5.15 Billion 2024 2032

Prognosezeitraum	2025 –2032
Marktgröße (Basisjahr)	USD 2.86 Billion
Marktgröße (Prognosejahr)	USD 5.15 Billion
CAGR	6.50 %
Wichtige Marktteilnehmer	Zoetis Services LLC Merck & Co. Inc. Elanco or its affiliates. C.H. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES INC

Markt für Veterinärmedizin im Nahen Osten und in Afrika, nach Typ (Therapeutika und Diagnostika), Anwendung (bakterielle Erkrankungen, atopische Dermatitis bei Hunden, Häminthes-Infektion, Tierkrebs, Maul- und Klauenseuche, Autoimmunerkrankungen, Blauzungenkrankheit und andere), Tierart (Haustiere und Nutztiere), Endverbraucher (Tierkliniken, Tierkliniken, Tier- und Veterinärfarmen, Referenzlabore, akademische und Forschungsinstitute, Point-of-Care-Tests/In-House-Tests und andere), Vertriebskanäle (Einzelhandel, Direktausschreibungen und andere) – Branchentrends und Prognose bis 2032

Marktanalyse für Veterinärmedizin im Nahen Osten und Afrika

Der Markt für Veterinärmedizin im Nahen Osten und Afrika wächst rasant. Dies ist auf die zunehmende Zahl von Haustierbesitzern, das steigende Bewusstsein für Tiergesundheit und Fortschritte in der tierärztlichen Versorgung zurückzuführen. Die Nachfrage nach Spezialbehandlungen, Impfstoffen, Antibiotika und entzündungshemmenden Medikamenten steigt, ebenso wie der Bedarf an besserer Krankheitsprävention und -behandlung bei Haus- und Nutztieren. Technologische Fortschritte wie Biologika und digitale Diagnosetools erweitern die Behandlungsmöglichkeiten zusätzlich. Die zunehmende Verbreitung von Zoonosen und der Fokus auf präventive Maßnahmen tragen ebenfalls zum Marktwachstum bei. Steigende Ausgaben für die Tiergesundheit und das Nutztiermanagement versprechen dem Veterinärmedizinmarkt ein nachhaltiges Wachstum.

Marktgröße für Veterinärmedizin im Nahen Osten und Afrika

Der Markt für Veterinärmedizin im Nahen Osten und in Afrika soll von 2,86 Milliarden US-Dollar im Jahr 2024 auf 5,15 Milliarden US-Dollar im Jahr 2032 anwachsen und im Prognosezeitraum 2025 bis 2032 eine CAGR von 6,5 % erreichen. Neben Einblicken in Marktszenarien wie Marktwert, Wachstumsrate, Segmentierung, geografische Abdeckung und wichtige Akteure enthalten die von Data Bridge Market Research kuratierten Marktberichte auch Import-Export-Analysen, eine Übersicht über die Produktionskapazität, eine Analyse des Produktionsverbrauchs, eine Preistrendanalyse, ein Szenario des Klimawandels, eine Lieferkettenanalyse, eine Wertschöpfungskettenanalyse, eine Übersicht über Rohstoffe/Verbrauchsmaterialien, Kriterien für die Lieferantenauswahl, eine PESTLE-Analyse, eine Porter-Analyse und regulatorische Rahmenbedingungen.

Markttrends für Veterinärmedizin im Nahen Osten und Afrika

„Zunahme der Haustierhaltung und Fortschritte“

The Middle East and Africa veterinary medicine market is witnessing significant growth driven by increasing pet ownership, rising animal health awareness, and advancements in veterinary care. The market is shifting toward more specialized treatments for both companion animals and livestock. A growing demand for vaccines, antibiotics, and anti-inflammatory medications is leading to innovations in drug formulations, contributing to better disease prevention and management.The increasing adoption of preventive care practices, such as routine vaccinations and health check-ups, further boosts the market. Moreover, the surge in zoonotic diseases and the need for better disease control in livestock farming are propelling the demand for veterinary medicines.

Report Scope and Middle East and Africa Veterinary Medicine Market Segmentation

Attributes	Middle East and Africa Veterinary Medicine Market Insights
Segments Covered	By Type: Therapeutics and Diagnostics By Application: Bacterial Diseases, Canine Atopic Dermatitis, Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others By Animal Type: Companion Animals and Production Animal By End User: Veterinary Hospitals, Veterinary Clinics, Animal and Veterinary Farm By Reference: Laboratories, Academic and Research Institute, Point-Of-Care Testing/In-House Testing, and Others By Distribution Channel: Retail Sales, Direct Tender, and Others
Region Covered	South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, Qatar, Oman, Bahrain, and Rest of Middle East and Africa
Key Market Players	Zoetis Services LLC (U.S.), Merck & Co., Inc. (U.S.), Elanco or its affiliates. (U.S.),C.H. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES, INC(Germany), AB Science (France),AdvaCare Pharma (U.S.), ALMAX IMAGING srl (Italy), Anivive (U.S.), BIOMÉRIEUX (France), Bionote USA Inc. (U.S.), Bio-Rad Laboratories (U.S.), Inc., CANON MEDICAL SYSTEMS EUROPE B.V. (Japan), Cargill, Incorporated (U.S.), Ceva (France), CureLab Oncology (U.S.), Dechra Pharmaceuticals Limited (UK), Demeditec Diagnostics GmbH (Germany), DHN International (U.S.), Diagnostic Imaging Systems (U.S.), ESAOTE SPA (Italy), Eurofins Scientific (Luxembourg), Evonik Industries AG (Germany), FUJIFILM Holdings Corporation (Japan), Gold Standard Diagnostics (U.S.), Hallmarq Veterinary Imaging(UK), Hebei Veyong pharmaceutical Co., Ltd. (China), Heska Corporation (U.S.),IBIS S.R.L. (Italy),Karyopharm (U.S.), Meridian Bioscience, Inc. (U.S.),Narang Medical Limited (India), Neogen Corporation (U.S.), NIPPON ZENYAKU KOGYO CO., LTD. (Japan), Novavive Inc. (U.S.), Nutreco (Netherlands), PLANMECA OY (Finland),RINGPU BIOLOGY Co., Ltd. (China), Shenzhen SONTU Medical Imaging Equipment Co., Ltd (China), Thermo Fisher Scientific Inc. (U.S.), Torigen Pharmaceuticals Inc (U.S.)., VetDC (U.S.), Vetoquinol(France), Virbac(France), VMRD, Inc. (U.S)
Market Opportunities	Growth in Animal Health Biotechnology Increasing Number of Animals Leading to the Demand of Veterinary Medicine Growth in Demand for Nutritional Supplements
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Middle East and Africa Veterinary Medicine Market Definition

The Middle East and Africa veterinary medicine market refers to the industry focused on the development, production, and distribution of pharmaceutical products and treatments designed to improve the health and well-being of animals. This market includes medications for both companion animals, such as pets, and livestock, including cattle, poultry, and horses. Veterinary medicines encompass a wide range of products, including vaccines, antibiotics, anti-inflammatory drugs, parasiticides, and biologics, which are used for disease prevention, treatment, and overall health management.

Middle East and Africa Veterinary Medicine Market Dynamics

Drivers

Increasing Pet Ownership Boosts Demand for Veterinary Services

The Global veterinary medicine market has experienced significant growth in recent years, driven by an increasing trend in pet ownership and a growing awareness of animal care. As more individuals and families welcome pets into their homes, there is a heightened recognition of the need for professional veterinary services to ensure the health and well-being of these animals. Pet owners are becoming more conscious of the importance of regular veterinary check-ups, preventive care, vaccinations, and early detection of diseases, prompting a surge in demand for veterinary medicines and treatments. In addition, the rise in animal healthcare awareness has led to greater acceptance and adoption of advanced diagnostic tools, therapeutic interventions, and specialized treatments that improve the quality of life for pets. This growing awareness extends beyond traditional pets like dogs and cats, as pet ownership now includes exotic animals, birds, and other species, further diversifying the veterinary medicine market. The increase in disposable income, especially in emerging economies, has allowed more pet owners to afford and prioritize veterinary care, fueling market growth. The expanding pet insurance market also plays a role in driving demand for veterinary medicines, as pet owners seek to protect their pets against unexpected medical expenses. Moreover, the shift towards e-commerce and online veterinary consultations has provided greater accessibility to veterinary products, creating a broader global market for both prescription and over-the-counter veterinary medications. This combination of increased pet ownership, greater awareness of animal health, and advancements in veterinary medicine has created a dynamic and rapidly evolving market, positioning veterinary medicine as a key segment within the broader healthcare industry.

For instance,

In September 2021, according to the article published by ReserchGate India's growing pet industry is fueled by increasing awareness of pet care, lifestyle changes, and rising incomes. Pet owners, treating pets as family, invest in health, food, and accessories. Factors like urbanization, pet humanization, and evolving consumer preferences drive this growth, leading to higher pet ownership and awareness.
In May 2023, according to the article published by the Times of India , India's growing awareness of animal welfare is driven by the Prevention of Cruelty to Animals Act, 1960, and initiatives like the Animal Birth Control program. NGOs, such as People for Animals and the Blue Cross of India, actively promote animal protection, rescue efforts, and education, fostering greater pet ownership and care awareness.

Zusammenfassend lässt sich sagen, dass der globale Markt für Veterinärmedizin ein starkes Wachstum verzeichnet hat, das vor allem auf die zunehmende Haustierhaltung und das gestiegene Bewusstsein für die Tierpflege zurückzuführen ist. Immer mehr Menschen adoptieren Haustiere und erkennen den dringenden Bedarf an professionellen tierärztlichen Leistungen. Dies führt zu einem sprunghaften Anstieg der Nachfrage nach Tierarzneimitteln, Behandlungen und Vorsorge. Dieser Trend hin zu proaktiver Tiergesundheit hat auch die Einführung fortschrittlicher Diagnoseinstrumente und spezialisierter Behandlungen vorangetrieben, die einem breiteren Spektrum an Haustieren, darunter auch exotischen Tieren und Vögeln, zugutekommen. Das steigende verfügbare Einkommen in Schwellenländern und der expandierende Markt für Haustierversicherungen tragen zusätzlich zu diesem Wachstum bei und ermöglichen es Tierhaltern, die Gesundheitsversorgung ihrer Haustiere zu priorisieren. Darüber hinaus hat der Aufstieg des E-Commerce und der Online-Beratung den Zugang zu Veterinärprodukten verbessert und den Markt für verschreibungspflichtige und rezeptfreie Medikamente erweitert. Der zunehmende Fokus auf die Tiergesundheit und die kontinuierlichen Fortschritte in der Veterinärmedizin haben diesen Sektor letztendlich zu einem wichtigen Akteur in der gesamten Gesundheitsbranche gemacht.

Zunehmende Tierkrankheiten erfordern eine verbesserte tierärztliche Versorgung

Der Anstieg von Tierkrankheiten, insbesondere von Infektionskrankheiten und chronischen Erkrankungen, ist zu einem wichtigen Wachstumstreiber im globalen Veterinärmedizinmarkt geworden. Da Krankheiten wie das Hundeparvovirus, die Katzenleukämie und neu auftretende Zoonosen wie die Vogelgrippe und die Schweinegrippe weiterhin sowohl Haus- als auch Nutztiere betreffen, steigt die Nachfrage nach tierärztlichen Behandlungen und Präventionsmaßnahmen. Die zunehmende Verbreitung chronischer Erkrankungen wie Arthritis, Diabetes und Fettleibigkeit bei Haustieren sowie die Zunahme von Infektionskrankheiten unterstreichen die Bedeutung von Früherkennung, Impfung und kontinuierlichem Management und erhöhen den Bedarf an fortschrittlicher tierärztlicher Versorgung zusätzlich. Darüber hinaus hat der Anstieg der Krankheiten zu einer stärkeren Betonung von Biosicherheitsmaßnahmen, diagnostischen Tests sowie der Entwicklung neuer Impfstoffe und Therapeutika geführt, was zu einem Anstieg veterinärpharmazeutischer Innovationen geführt hat. Mit der zunehmenden weltweiten Tierpopulation, insbesondere in dicht besiedelten städtischen Gebieten, steigt die Wahrscheinlichkeit der Ausbreitung von Krankheiten, was die kontinuierliche Entwicklung und Bereitstellung von Tierarzneimitteln zur Minderung von Gesundheitsrisiken erforderlich macht. Die zunehmende Häufigkeit von Krankheitsausbrüchen und das gestiegene öffentliche Bewusstsein für die Bedeutung der Tiergesundheit haben Investitionen in Forschung und Entwicklung vorangetrieben und die Veterinärmedizin weiterentwickelt, um ein breites Spektrum an Herausforderungen im Bereich der Tiergesundheit zu bewältigen. Daher wird erwartet, dass die Nachfrage nach Veterinärprodukten – von Antibiotika und Virostatika bis hin zu Impfstoffen und Nutrazeutika – weiter steigen wird, was den Veterinärmedizinmarkt zu einem wichtigen Segment der globalen Gesundheitsbranche macht.

Zum Beispiel,

Laut einem im Juni 2022 vom NCBI veröffentlichten Artikel stellen Zoonosen, die jährlich für Millionen von Erkrankungen und Todesfällen beim Menschen verantwortlich sind, ein erhebliches Risiko für die öffentliche Gesundheit dar, wie die SARS-CoV-2-Pandemie zeigt. Diese Krankheiten beeinträchtigen die Gesundheit von Mensch, Tier und Umwelt und verursachen wirtschaftliche Schäden durch Gesundheitskosten, Produktionsausfälle in der Viehzucht und Störungen des Ökosystems. Dies unterstreicht die Notwendigkeit wirksamer Präventionsstrategien.
Laut einem im Juni 2021 im Indian Journal of Medical Research veröffentlichten Artikel begünstigt der zunehmende Mensch-Tier-Kontakt, der durch Abholzung, die Nachfrage nach Wildtierprodukten und landwirtschaftliche Praktiken verursacht wird, die Entstehung von Zoonosen wie COVID-19. Diese Ausbrüche verursachen erhebliche gesundheitliche und wirtschaftliche Verluste. Unzureichende öffentliche Gesundheitssysteme und der Mangel an interdisziplinären Ansätzen unterstreichen die Notwendigkeit umfassender Strategien zum Schutz von Wildtieren, zur Landnutzung und zur Krankheitsprävention.

Der Anstieg von Tierkrankheiten, sowohl infektiösen als auch chronischen, treibt das Wachstum des globalen Veterinärmedizinmarktes maßgeblich voran. Erkrankungen wie das Canine Parvovirus, die Katzenleukämie und neu auftretende Zoonosen erhöhen die Nachfrage nach tierärztlicher Behandlung und Vorsorge. Auch chronische Erkrankungen wie Arthritis und Diabetes treten häufiger auf und erfordern daher kontinuierliches Management und Früherkennung. Dies hat zu höheren Investitionen in Biosicherheit, diagnostische Tests, Impfstoffe und Therapeutika geführt. Da Krankheitsausbrüche, insbesondere in städtischen Gebieten, häufiger werden, steigt die Nachfrage nach Tierarzneimitteln weiter an und macht die tierärztliche Versorgung zu einem wichtigen Segment der globalen Gesundheitsversorgung.

Gelegenheiten

Steigende Zahl von Tieren führt zur Nachfrage nach Veterinärmedizin

Die steigende Zahl an Tieren, insbesondere in der Viehzucht, bietet dem globalen Veterinärmedizinmarkt erhebliche Chancen. Angesichts der wachsenden Weltbevölkerung und der damit verbundenen Nachfrage nach Fleisch, Milchprodukten und anderen tierischen Produkten besteht ein dringender Bedarf an leistungsfähigen, produktiven und gesunden Nutztieren. Da Landwirte bestrebt sind, ihre Produktivität zu maximieren und das Tierwohl zu gewährleisten, wird die Nachfrage nach tierärztlichen Dienstleistungen und Produkten wie Impfstoffen, Antibiotika und Nahrungsergänzungsmitteln steigen. Dieses Wachstum wird zusätzlich durch die Notwendigkeit vorangetrieben, Krankheitsausbrüche zu verhindern und die Lebensmittelsicherheit zu gewährleisten, die für die öffentliche und tierische Gesundheit von entscheidender Bedeutung sind. Angesichts der steigenden Zahl an Nutztieren wird die Veterinärmedizin daher eine entscheidende Rolle bei der Unterstützung dieser Branche spielen.

Zum Beispiel,

In March 2021, according to an article published in the Frontiers in Veterinary Science, there are about one billion goats worldwide, and the global goat population has more than doubled during the last four decades. According to the Food and Agriculture Organization, over 90% of goats are found in developing countries; Asia has the largest proportion of the world's goat population, followed by Africa

Moreover, advancements in agricultural practices and the shift towards intensive farming systems are creating additional opportunities within the veterinary medicine market. As farms grow larger and more complex, the health management strategies required to maintain high standards of animal welfare and biosecurity become increasingly sophisticated. This progress opens up avenues for innovative veterinary technologies, including diagnostic tools and health monitoring systems that help farmers identify and mitigate health risks promptly. In addition, the growing emphasis on sustainable farming practices and responsible use of medications is driving the development of more targeted and eco-friendly veterinary products. This alignment of veterinary medicine with evolving agricultural practices generates a fertile ground for growth, innovation, and collaboration among veterinarians, farmers, and pharmaceutical companies.

Growth In Animal Health Biotechnology

The growth in animal health biotechnology presents a significant opportunity for the Global veterinary medicine market by facilitating the development of innovative and targeted solutions for animal health management. Advancements in biotechnology, such as genetic engineering, gene therapy, and immunology, enable the creation of vaccines tailored to specific diseases, improving their efficacy and safety. This shift towards biotechnological approaches addresses the increasing concerns over antibiotic resistance in livestock, as biotechnology can lead to the development of alternatives to traditional antibiotics, thereby ensuring healthier animals and enhancing food safety. As consumers demand safer and higher-quality animal products, the application of biotechnology in veterinary medicine can meet these expectations while facilitating more sustainable agricultural practices.

For instance,

In September 2023, according to an article published by ResearchGate, Animal biotechnology represents a cutting-edge field that has revolutionized our interactions with the animal kingdom. Recent advancements encompass various domains, including genetic editing techniques like CRISPR-Cas9, which allow precise genetic modifications for improved animal health and product quality.
In August 2024, according to an article published by the National Institute of Food and Agriculture, Advances in animal biotechnology have been facilitated by recent progress in sequencing animal genomes, gene expression and metabolic profiling of animal cells. More recently, genome editing technologies (Zinc Finger Nucleases, TALENS, and CRISPR-Cas systems) have opened up new opportunities to easily create genetic variations in animals that can improve their health and well-being, agricultural production, and protection against diseases.

In addition, the integration of biotechnology into animal health fosters improved diagnostics and treatments that can enhance animal welfare and productivity. Tools derived from biotechnological advancements, such as molecular diagnostics and biomarker identification, allow for more precise disease detection and monitoring, enabling veterinarians to implement timely interventions. This not only benefits the health of the animals but also reduces economic losses for farmers due to disease outbreaks and suboptimal productivity. The growing emphasis on precision veterinary medicine—leveraging data to tailor interventions—further amplifies the demand for biotechnological innovations. As a result, stakeholders in the Global Veterinary Medicine Market—including pharmaceutical companies, researchers, and technology developers—stand to gain significantly as they invest in and harness the potential of animal health biotechnology to improve outcomes for both animals and the agricultural sector as a whole.

Restraints/Challenges

High Veterinary Care Costs Limit Market Accessibility

The high cost of veterinary care represents a significant restraint on market accessibility, directly impacting both pet owners and livestock producers globally. For pet owners, the expense associated with advanced diagnostics, surgeries, and specialty care often leads to difficult healthcare decisions, with many opting for cost-effective solutions or delaying necessary treatments for their animals. This has driven a growing demand for affordable alternatives such as over-the-counter medications, preventive care treatments, and vaccines. In addition, pet insurance has become a more popular option to offset the financial burden of veterinary services. In parallel, livestock producers, particularly in developing economies, face financial constraints that hinder their ability to access the full spectrum of veterinary care required to maintain optimal animal health. This limitation affects the quality of care they can provide to their animals, leading to an increased need for more cost-efficient solutions like generic medications, nutraceuticals, and vaccines for disease prevention. The high costs also spur innovation within the veterinary industry as companies seek to develop affordable treatments that do not sacrifice quality. Furthermore, as veterinary care becomes more specialized and reliant on advanced technologies, the focus is shifting toward streamlining services and implementing preventive care models. These models aim to reduce long-term costs for both pet owners and agricultural producers, emphasizing the importance of cost efficiency in shaping the evolution of the veterinary medicine market. Despite these efforts, the high cost of veterinary services remains a major barrier, limiting accessibility and influencing the growth trajectory of the market.

For instance,

In July 2024, according to the article published by NCBI, veterinary procedure costs, such as dog and cat GDY, saw significant increases between autumn 2022 and winter 2023/2024, with prices rising by 2–24%. Emergency surgeries and equine GDY also experienced sharp cost hikes, highlighting the financial burden of veterinary care, with substantial price variations across countries and procedures.
In July 2020, according to the article published by NCBI, despite the growing popularity of dog ownership, veterinary visits have declined, while the average cost per visit has risen from USD 138 to USD 161. Increased labor costs, medical supplies, and equipment contribute to the higher expenses. Pet health insurance also raises veterinary spending, impacting pet owners’ overall care costs.

In conclusion, the high cost of veterinary care is a significant driver in the global veterinary medicine market, influencing both pet owners and livestock producers to seek more affordable and accessible solutions. This has led to a rising demand for cost-effective products such as vaccines, preventive treatments, and generics. In addition, the high costs are encouraging innovation within the industry, with a focus on developing affordable, quality treatments and streamlining services. As both pet and livestock owners seek to manage expenses, the demand for economical veterinary care options will continue to shape the growth and evolution of the veterinary medicine market.

Challenges Of Regulatory Compliance And Complexity

Regulatory and compliance issues are significant challenges in the veterinary medicine market due to the complex, region-specific requirements that companies must navigate to ensure their products meet safety standards and are approved for use. Different countries and regions have varying regulatory bodies, each with its own set of guidelines for the approval of veterinary medicines. For instance, in the U.S., the Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of veterinary products, while in the European Union, the European Medicines Agency (EMA) regulates these products. These regulatory bodies often have rigorous and time-consuming approval processes, including extensive testing, documentation, and periodic reviews, which can delay the launch of new veterinary medicines.

Moreover, the increasing focus on animal welfare and environmental safety has introduced additional layers of complexity. Compliance with these regulations often requires manufacturers to conduct more comprehensive research, including animal testing and long-term safety assessments, which can be costly and time-consuming. In certain countries, regulations may be stricter or less transparent, creating uncertainties and slowing down market entry. Companies must also adapt their products to meet different regulatory frameworks for different markets, which can further complicate product distribution and increase operational costs.

For instance,

In July 2024, according to an news published by Rebexa Group, Navigating diverse regulatory requirements across regions creates significant challenges for the global veterinary medicine market. Varying approval processes, safety standards, and animal welfare regulations increase costs and delay product launches. Emerging concerns, like antimicrobial resistance, lead to evolving guidelines, further complicating compliance and hindering the market's growth potential.
In July 2021, according to an article published by ScienceDriect the complexities of global veterinary medicine regulations, noting that each country, such as the USA, EU, and Australia, has different approval processes and safety standards. The absence of unified frameworks for zoonotic diseases, veterinary drug stockpiling, and pharmacovigilance centers in many nations adds to the challenge, hindering market development and consistency in veterinary care globally.

Regulatory and compliance challenges create significant barriers to entry, delay product availability, and increase costs for companies in the veterinary medicine market. Addressing these obstacles through streamlined processes and international regulatory harmonization could alleviate some of the pressure, enabling faster market access, better alignment with animal health needs, and ultimately improved animal welfare worldwide.

Middle East and Africa Veterinary Medicine Market Scope

Middle East and Africa veterinary medicine market is segmented into five notable segments based on type, application, animal type, end user, and distribution channel The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

Therapeutics
- Pharmaceuticals
  - Antibiotics
    - Tetracycline
    - Penicillins
    - Macrolides
    - Aminoglycosides
    - Lincosamides
    - Colistin
    - Others
  - Parasiticides
    - Benzimidazoles
    - Macrocyclic Lactones
    - Pyrethroids
    - Amprolium
    - Nitroimidazoles
    - Piperazine
    - Others
  - Anlagesics/Anti-Inflammatory (Nsaids)
    - Carprofen
    - Meloxicam
    - Phenylbutazone
    - Acetaminophen
    - Firocoxib
    - Deracoxib
    - Others
  - Antihistamines
    - Cetirizine
    - Brompheniramine
    - Diphenhydramine
    - Terfenadine
    - Trimeprazine
    - Others
  - Corticosteroids
    - Dexamethasone
    - Prednisolone
    - Prednisone
    - Others
  - Antibloat
    - Docusate
    - Simethicone
    - Others
  - Hormonal
    - Equine Chorionic Gonadotropin
    - Cloprostenol
    - Oxytocin
    - Others
- Opioids
  - Mu Agonists
    - Methadone
    - Meperidine
    - Morphine
    - Oxymorphone
    - Others
  - Partial Mu Agonist
    - Buprenorphine
    - Others
  - Kappa Agonist-Mu Anatgonist
    - Butorphanol
    - Others
- Others
- Branded
- Generic
- Prescription Based
- Over The Counter
- Oral
  - Tablets
  - Solutions
  - Powder
  - Others
- Parental
  - Intraveneous
  - Subcutaneous
  - Others
- Topical
- Others
Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- Others
Biologics
- Marketed
  - Toceranib
  - Lomustine
  - Cyclophosphamide
  - Chlorambucil
  - Others
- Emerging
Medicated Feed Additives
- Enzymes
  - Phytase
  - Carbohydrase
  - Protease
  - Amylase
  - Cellulase
  - Mannase
  - Glucanase
  - Xylanase
  - Others
Amino Acid
- Lysine
- Methionine
- Threonine
- Tryptophan
- Others
Vitamins
- Fat-Soluble Vitamin
  - Vitamin A
  - Vitamin E
  - Vitamin D
  - Vitamin K
- Water-Soluble Vitamin
  - Vitamin B Complex
  - Vitamin C
Antioxidants
- Bha
- Bht
- Ethoxyquin
- Others
Probiotics
- Lactobacilli
- Bifidobacteria
- Yeast
- Stretococcus Thermophilus
Feed Acidifiers
- Propionic Acid
- Formic Acid
- Lactic Acid
- Citric Acid
- Others
Mycotoxin Detoxifiers
- Mycotoxin Binders
  - Silicates
  - Clays
  - Chemical Polymers
  - Glucan Products
  - Others
- Mycotoxin Modifiers
Phytogenic
- Essential Oils
- Herbs & Spices
- Oleoresin
- Others
Carotenoids
- Beta-Carotene
- Astaxanthin
- Lutein
- Canthaxanthin
Spurenelemente
- Zink
- Kupfer
- Mangan
- Eisen
- Selen
- Sonstiges
Konservierungsmittel
- Trennmittel
- Schimmelhemmer
Aromen und Süßstoffe
- Geschmacksrichtungen
- Süßstoffe
  - Saccharin
  - Neohesperidin-Dihydrochalcon
  - Glycyrrhizin
  - Thaumatin
  - Sonstiges
- Sonstiges
Diagnose
- Instrumente & Geräte
  - Bildgebungsgeräte
    - Röntgenbildgebung (Radiographie)
      - Kleine Tiere
      - Große Tiere
    - Ultraschall
      - Kleine Tiere
      - Große Tiere
    - Computertomographie
      - Kleine Tiere
      - Große Tiere
    - Magnetresonanztomographie
      - Kleine Tiere
      - Große Tiere
    - Einzelphotonen-Emissionscomputertomographie (Spect)
      - Kleine Tiere
      - Große Tiere
    - Sonstiges
Laborinstrumente
- Hämatologie-Analysatoren
  - Automatisch
  - Halbautomatisch
  - Hohe Preisspanne
  - Standard-Preisspanne
  - Tischgerät
  - Tragbar
  - Sonstiges
- Chemieanalysatoren
  - Automatisch
  - Halbautomatisch
  - Tischgerät
  - Tragbar
  - Blut
  - Urin
  - Hocker
  - Sonstiges
- Point-of-Care-Instrumente
  - Lateral-Flow-Punkt
  - Molekularer Punkt
  - Sonstiges
- Gerinnungsanalysatoren
  - Automatisch
  - Halbautomatisch
  - 4-Kanal
  - 1-Kanal
  - Vollblut
  - Plasma
  - Tischgerät
  - Tragbar
- Urinanalysegeräte
  - Automatisch
  - Halbautomatisch
- Refraktometer
  - Optisch
  - Digital
  - Tischgerät
  - Tragbar
- Sonstiges
Reagenzien und Verbrauchsmaterialien
- Bausätze
  - PCR-Kits
  - Schnelltest-Kits
  - Multiplex-Kits
  - Elisa Kits
  - Probenvorbereitungskits Isolierungs- und Extraktionskits
  - Sonstiges
- Reagenzien
  - Reagenzien zur Nukleinsäureextraktion
  - Immunfluoreszenz-Reagenzien
  - Coombs-Reagenzien
  - Andere Reagenzien
Medien
Panel
Streifen
Kassette
Kontrollstandards
Sonden und Primer
Andere Verbrauchsmaterialien und Zubehör

Anwendung

Bakterielle Erkrankungen
- Nutztiere
- Haustiere
Atopische Dermatitis beim Hund
- Haustiere
- Nutztiere
Häminthes-Infektion
- Nutztiere
- Haustiere
Tierkrebs
- Haustiere
- Nutztiere
Maul- und Klauenseuche
- Nutztiere
- Haustiere
Autoimmunerkrankungen
- Haustiere
- Nutztiere
Blauzungenkrankheit
- Nutztiere
- Haustiere
Sonstiges
- Haustiere
- Nutztiere

Tierart

Haustiere
- Hunde
- Katzen
- Pferde
- Sonstiges
Nutztiere
- Geflügel
- Vieh
- Schwein
- Fisch
- Schafe & Ziegen
- Sonstiges

Endbenutzer

Tierkliniken
- Privat
- Öffentlich
- Stufe 2
- Stufe 1
- Stufe 3
Tierkliniken
- Öffentlich
- Privat
Tier- und Veterinärfarmen
Referenzlabore
Akademisches und Forschungsinstitut
Point-of-Care-Tests/In-House-Tests
Sonstiges

Vertriebskanal

Einzelhandelsumsätze
- Offline
  - Krankenhausapotheke
  - Einzelhandelsapotheke
- Online
  - E-Commerce-Plattformen
  - Unternehmenswebsite
  - Sonstiges
Direkte Ausschreibung
Sonstiges

Regionale Analyse des Veterinärmedizinmarktes im Nahen Osten und Afrika

Der Markt wird analysiert und es werden Einblicke in die Marktgröße und Trends basierend auf Land, Typ, Anwendung, Tierart, Endbenutzer und Vertriebskanal wie oben angegeben bereitgestellt.

Die vom Markt abgedeckten Länder sind Saudi-Arabien, die Vereinigten Arabischen Emirate, Südafrika, Ägypten, Israel und der Rest des Nahen Ostens und Afrikas.

Saudi-Arabien wird voraussichtlich den Veterinärmedizinmarkt im Nahen Osten und Afrika dominieren. Grund dafür sind die fortschrittliche Gesundheitsinfrastruktur, die steigende Anzahl an Haustieren, die zunehmende Viehzucht, hohe Investitionen in Forschung und Entwicklung sowie eine unterstützende Regierungspolitik. Die starke Pharmaindustrie der Region, das wachsende Bewusstsein für Tiergesundheit und die hohen Ausgaben für Veterinärmedizin treiben Marktwachstum und Innovation zusätzlich voran.

Südafrika dürfte aufgrund der rasanten Urbanisierung, der zunehmenden Haustierhaltung, der steigenden Viehproduktion und des wachsenden Bewusstseins für Tiergesundheit den Veterinärmedizinmarkt im Nahen Osten und Afrika schnell wachsen lassen. Der Ausbau der veterinärmedizinischen Infrastruktur, staatliche Förderung, Fortschritte in der Biotechnologie und steigende verfügbare Einkommen treiben das Marktwachstum weiter voran und machen die Region zu einem wichtigen Akteur in der Veterinärmedizin.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Middle East and Africa Veterinary Medicine Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Middle East and Africa Veterinary Medicine Market Leaders Operating in the Market Are:

Zoetis Services LLC (U.S.)
Merck & Co., Inc. (U.S.)
Elanco or its affiliates (U.S.)
C.H. Boehringer Ingelheim International GmbH (Germany)
IDEXX LABORATORIES, INC (Germany)
AB Science (France)
AdvaCare Pharma (U.S.)
ALMAX IMAGING srl (Italy)
Anivive (U.S.)
BIOMÉRIEUX (France)
Bionote USA Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
CANON MEDICAL SYSTEMS EUROPE B.V. (Japan)
Cargill, Incorporated (U.S.)
Ceva (France)
CureLab Oncology (U.S.)
Dechra Pharmaceuticals Limited (UK)
Demeditec Diagnostics GmbH (Germany)
DHN International (U.S.)
Diagnostic Imaging Systems (U.S.)
ESAOTE SPA (Italy)
Eurofins Scientific (Luxembourg)
Evonik Industries AG (Germany)
FUJIFILM Holdings Corporation (Japan)
Gold Standard Diagnostics (U.S.)
Hallmarq Veterinary Imaging (UK)
Hebei Veyong Pharmaceutical Co., Ltd. (China)
Heska Corporation (U.S.)
IBIS S.R.L. (Italy)
Karyopharm (U.S.)
Meridian Bioscience, Inc. (U.S.)
Narang Medical Limited (India)
Neogen Corporation (U.S.)
NIPPON ZENYAKU KOGYO CO., LTD. (Japan)
Novavive Inc. (U.S.)
Nutreco (Netherlands)
PLANMECA OY (Finland)
RINGPU BIOLOGY Co., Ltd. (China)
Shenzhen SONTU Medical Imaging Equipment Co., Ltd (China)
Thermo Fisher Scientific Inc. (U.S.)
Torigen Pharmaceuticals Inc. (U.S.)
VetDC (U.S.)
Vetoquinol (France)
Virbac (France)
VMRD, Inc. (U.S.)

Latest Developments Middle East and Africa Veterinary Medicine Market

In February 2023 , Vetoquinol introduces Lygoferrin, a scientifically formulated, natural immunity booster designed to strengthen defense mechanisms in animals. This innovative product enhances resistance against infections by supporting the body's innate immune response. Lygoferrin helps reduce dependency on antibiotics, promoting overall health and well-being in livestock and companion animals. Its advanced formula ensures rapid absorption and effective protection, minimizing the risk of bacterial and viral infections. With this launch, Vetoquinol reinforces its commitment to sustainable animal health solutions, providing veterinarians and farmers with a reliable, natural alternative to enhance immunity and improve productivity in animal care
In February 2023, Vetoquinol introduces Immun-C Aqua, an advanced water-soluble immune booster designed to enhance the health and resilience of aquatic species. This innovative formula strengthens disease resistance, improves overall vitality, and optimizes growth performance in fish and shrimp farming. By fortifying the immune system, Immun-C Aqua helps reduce mortality rates and enhances survival in challenging environments. With a scientifically developed composition, it ensures rapid absorption and effective action, contributing to sustainable and productive aquaculture. This launch underscores Vetoquinol’s commitment to providing high-quality, research-backed solutions for the aquaculture industry, supporting healthier aquatic livestock and improving farm profitability
In January 2025 , Laurie Hueneke Martens, Associate VP of Middle East and Africa Public Policy and Government Relations at Merck Animal Health, received the 8th Annual Feather in Her Cap Award. Recognized for her leadership in public policy and mentoring future women leaders, Hueneke also saw a USD 5,000 donation made to her chosen animal charities
In February 2024, Merck Animal Health announced that the European Commission has granted marketing authorization for BRAVECTO TriUNO, a new chewable tablet for dogs. This product targets both internal and external parasites, offering protection against fleas, ticks, gastrointestinal nematodes, heartworm, and angiostrongylosis. It is now approved in multiple countries, including Peru and Costa Rica
In November 2024, Merck Animal Health announced the winners of the 2024 High-Quality Pork Pignnovation Award. Romain Delcombel of BioAZ won Champion, with Joao Lopes of Redsoft Technologica LTDA as Runner-Up and Jaap de Wit of Westfort in third. The awards recognize their innovative contributions to swine industry advancements in health, welfare, and sustainability

SKU-73750

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Klicken Sie auf das Bild, um es zu vergrößern

Interaktives Datenanalyse-Dashboard
Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
Zugriff für Research-Analysten für Anpassungen und Abfragen
Konkurrenzanalyse mit interaktivem Dashboard
Aktuelle Nachrichten, Updates und Trendanalyse
Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung

Demo anfordern

Inhaltsverzeichnis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 DBMR MARKET POSITION GRID

2.8 MARKET END USER COVERAGE GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 PIPELINE ANALYSIS

4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET

4.5 EPIDEMIOLOGY

5 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES

6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE

6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS

6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS

6.2 RESTRAINTS

6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY

6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS

6.3 OPPORTUNITIES

6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE

6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY

6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS

6.4 CHALLENGES

6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY

6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS

7 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY TYPE

7.1 OVERVIEW

7.2 THERAPEUTICS

7.2.1 PHARMACEUTICALS

7.2.1.1 ANTIBIOTICS

7.2.1.1.1 TETRACYCLINE

7.2.1.1.2 PENICILLINS

7.2.1.1.3 MACROLIDES

7.2.1.1.4 AMINOGLYCOSIDES

7.2.1.1.5 LINCOSAMIDES

7.2.1.1.6 COLISTIN

7.2.1.1.7 OTHERS

7.2.1.2 PARASITICIDES

7.2.1.2.1 BENZIMIDAZOLES

7.2.1.2.2 MACROCYCLIC LACTONES

7.2.1.2.3 PYRETHROIDS

7.2.1.2.4 AMPROLIUM

7.2.1.2.5 NITROIMIDAZOLES

7.2.1.2.6 PIPERAZINE

7.2.1.2.7 OTHERS

7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS)

7.2.1.3.1 CARPROFEN

7.2.1.3.2 MELOXICAM

7.2.1.3.3 PHENYLBUTAZONE

7.2.1.3.4 ACETAMINOPHEN

7.2.1.3.5 FIROCOXIB

7.2.1.3.6 DERACOXIB

7.2.1.3.7 OTHERS

7.2.1.4 ANTIHISTAMINES

7.2.1.4.1 CETIRIZINE

7.2.1.4.2 BROMPHENIRAMINE

7.2.1.4.3 DIPHENHYDRAMINE

7.2.1.4.4 TERFENADINE

7.2.1.4.5 TRIMEPRAZINE

7.2.1.4.6 OTHERS

7.2.1.5 CORTICOSTEROIDS

7.2.1.5.1 DEXAMETHASONE

7.2.1.5.2 PREDNISOLONE

7.2.1.5.3 PREDNISONE

7.2.1.5.4 OTHERS

7.2.1.6 ANTIBLOAT

7.2.1.6.1 DOCUSATE

7.2.1.6.2 SIMETHICONE

7.2.1.6.3 OTHERS

7.2.1.7 HORMONAL

7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN

7.2.1.7.2 CLOPROSTENOL

7.2.1.7.3 OXYTOCIN

7.2.1.7.4 OTHERS

7.2.1.8 OPIOIDS

7.2.1.8.1 MU AGONISTS

7.2.1.8.1.1 METHADONE

7.2.1.8.1.2 MEPERIDINE

7.2.1.8.1.3 MORPHINE

7.2.1.8.1.4 OXYMORPHONE

7.2.1.8.1.5 OTHERS

7.2.1.8.2 PARTIAL MU AGONIST

7.2.1.8.2.1 BUPRENORPHINE

7.2.1.8.2.2 OTHERS

7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST

7.2.1.8.3.1 BUTORPHANOL

7.2.1.8.3.2 OTHERS

7.2.1.9 OTHERS

7.2.1.10 PHARMACEUTICALS BY DRUG TYPE

7.2.1.10.1 BRANDED

7.2.1.10.2 GENERIC

7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE

7.2.1.11.1 PRESCRIPTION BASED

7.2.1.11.2 OVER THE COUNTER

7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION,

7.2.1.12.1 ORAL

7.2.1.12.1.1 TABLETS

7.2.1.12.1.2 SOLUTIONS

7.2.1.12.1.3 POWDER

7.2.1.12.1.4 OTHERS

7.2.1.12.2 PARENTAL

7.2.1.12.2.1 INTRAVENOUS

7.2.1.12.2.2 SUBCUTANEOUS

7.2.1.12.2.3 OTHERS

7.2.1.12.3 TOPICAL

7.2.1.12.4 OTHERS

7.2.2 VACCINES

7.2.2.1 LIVE ATTENUATED VACCINES

7.2.2.2 TOXOID VACCINES

7.2.2.3 RECOMBINANT VACCINES

7.2.2.4 INACTIVATED VACCINES

7.2.2.5 OTHERS

7.2.3 BIOLOGICS

7.2.3.1 MARKETED

7.2.3.1.1 TOCERANIB

7.2.3.1.2 LOMUSTINE

7.2.3.1.3 CYCLOPHOSPHAMIDE

7.2.3.1.4 CHLORAMBUCIL

7.2.3.1.5 OTHERS

7.2.3.2 EMERGING

7.2.4 MEDICATED FEED ADDITIVES

7.2.4.1 ENZYMES

7.2.4.1.1 PHYTASE

7.2.4.1.2 CARBOHYDRASE

7.2.4.1.3 PROTEASE

7.2.4.1.4 AMYLASE

7.2.4.1.5 CELLULASE

7.2.4.1.6 MANNASE

7.2.4.1.7 GLUCANASE

7.2.4.1.8 XYLANASE

7.2.4.1.9 OTHERS

7.2.4.2 AMINO ACID

7.2.4.2.1 LYSINE

7.2.4.2.2 METHIONINE

7.2.4.2.3 THREONINE

7.2.4.2.4 TRYPTOPHAN

7.2.4.2.5 OTHERS

7.2.4.3 VITAMINS

7.2.4.3.1 FAT-SOLUBLE VITAMIN

7.2.4.3.1.1 VITAMIN A

7.2.4.3.1.2 VITAMIN E

7.2.4.3.1.3 VITAMIN D

7.2.4.3.1.4 VITAMIN K

7.2.4.3.2 WATER-SOLUBLE VITAMIN

7.2.4.3.2.1 VITAMIN B COMPLEX

7.2.4.3.2.2 VITAMIN C

7.2.4.4 ANTIOXIDANTS

7.2.4.4.1 BHA

7.2.4.4.2 BHT

7.2.4.4.3 ETHOXYQUIN

7.2.4.4.4 OTHERS

7.2.4.5 PROBIOTICS

7.2.4.6 LACTOBACILLI

7.2.4.7 BIFIDOBACTERIA

7.2.4.8 YEAST

7.2.4.9 STRETOCOCCUS THERMOPHILUS

7.2.4.10 FEED ACIDIFIERS

7.2.4.10.1 PROPIONIC ACID

7.2.4.10.2 FORMIC ACID

7.2.4.10.3 LACTIC ACID

7.2.4.10.4 CITRIC ACID

7.2.4.10.5 OTHERS

7.2.4.11 MYCOTOXIN DETOXIFIERS

7.2.4.11.1 MYCOTOXIN BINDERS

7.2.4.11.1.1 SILICATES

7.2.4.11.1.2 CLAYS

7.2.4.11.1.3 CHEMICAL POLYMERS

7.2.4.11.1.4 GLUCAN PRODUCTS

7.2.4.11.1.5 OTHERS

7.2.4.11.2 MYCOTOXIN MODIFIERS

7.2.4.12 PHYTOGENIC

7.2.4.12.1 ESSENTIAL OILS

7.2.4.12.2 HERBS & SPICES

7.2.4.12.3 OLEORESIN

7.2.4.12.4 OTHERS

7.2.4.13 CAROTENOIDS

7.2.4.13.1 BETA-CAROTENE

7.2.4.13.2 ASTAXANTHIN

7.2.4.13.3 LUTEIN

7.2.4.13.4 CANTHAXANTHIN

7.2.4.14 TRACE MINERALS

7.2.4.14.1 ZINC

7.2.4.14.2 COPPER

7.2.4.14.3 MANGANESE

7.2.4.14.4 IRON

7.2.4.14.5 SELENIUM

7.2.4.14.6 OTHERS

7.2.4.15 PRESERVATIVES

7.2.4.15.1 ANTICAKING AGENTS

7.2.4.15.2 MOLD INHIBITORS

7.2.4.16 FLAVOURS AND SWEETENERS

7.2.4.16.1 FLAVORS

7.2.4.16.2 SWEETENERS

7.2.4.16.2.1 SACCHARIN

7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE

7.2.4.16.2.3 GLYCYRRHIZIN

7.2.4.16.2.4 THAUMATIN

7.2.4.16.2.5 OTHERS

7.2.4.17 OTHERS

7.3 DIAGNOSTICS

7.3.1 INSTRUMENTS & DEVICES

7.3.1.1 IMAGING DEVICES

7.3.1.2 X-RAY IMAGING (RADIOGRAPHY)

7.3.1.2.1 SMALL ANIMALS

7.3.1.2.2 LARGE ANIMALS

7.3.1.3 ULTRASOUND

7.3.1.3.1 SMALL ANIMALS

7.3.1.3.2 LARGE ANIMALS

7.3.1.4 COMPUTED TOMOGRAPHY

7.3.1.4.1 SMALL ANIMALS

7.3.1.4.2 LARGE ANIMALS

7.3.1.5 MAGNETIC RESONANCE IMAGING

7.3.1.5.1 SMALL ANIMALS

7.3.1.5.2 LARGE ANIMALS

7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)

7.3.1.6.1 SMALL ANIMALS

7.3.1.6.2 LARGE ANIMALS

7.3.1.6.3 OTHERS

7.3.2 LABORATORY INSTRUMENTS

7.3.2.1 HEMATOLOGY ANALYZERS

7.3.2.1.1 BY MODE

7.3.2.1.1.1 AUTOMATIC

7.3.2.1.1.2 SEMI-AUTOMATIC

7.3.2.1.2 BY PRICE RANGE

7.3.2.1.2.1 HIGH PRICE RANGE

7.3.2.1.2.2 STANDARD PRICE RANGE

7.3.2.1.3 BY MODALITY,

7.3.2.1.3.1 BENCHTOP

7.3.2.1.3.2 PORTABLE

7.3.2.1.3.3 OTHERS

7.3.2.2 CHEMISTRY ANALYZERS

7.3.2.2.1 BY MODE

7.3.2.2.1.1 AUTOMATIC

7.3.2.2.1.2 SEMI-AUTOMATIC

7.3.2.2.2 BY MODALITY,

7.3.2.2.2.1 BENCHTOP

7.3.2.2.2.2 PORTABLE

7.3.2.2.3 BY SAMPLE TYPE,

7.3.2.2.3.1 BLOOD

7.3.2.2.3.2 URINE

7.3.2.2.3.3 STOOL

7.3.2.2.3.4 OTHERS

7.3.2.3 POINT-OF-CARE INSTRUMENTS

7.3.2.3.1 BY TYPE

7.3.2.3.1.1 LATERAL FLOW POCT

7.3.2.3.1.2 MOLECULAR POCT

7.3.2.3.1.3 OTHERS

7.3.2.3.2 BY MODE

7.3.2.3.2.1 AUTOMATIC

7.3.2.3.2.2 SEMI-AUTOMATIC

7.3.2.4 COAGULATION ANALYZERS

7.3.2.4.1 BY CHANNEL,

7.3.2.4.1.1.1 4-CHANNEL

7.3.2.4.1.1.2 1-CHANNEL

7.3.2.4.2 BY SAMPLE TYPE

7.3.2.4.2.1 WHOLE BLOOD

7.3.2.4.2.2 PLASMA

7.3.2.4.3 BY MODALITY,

7.3.2.4.3.1 BENCHTOP

7.3.2.4.3.2 PORTABLE

7.3.2.5 URINALYSIS EQUIPMENT

7.3.2.5.1 BY MODE

7.3.2.5.1.1 AUTOMATIC

7.3.2.5.1.2 SEMI-AUTOMATIC

7.3.2.6 REFRACTOMETER

7.3.2.6.1 BY MODE,

7.3.2.6.1.1 OPTICAL

7.3.2.6.1.2 DIGITAL

7.3.2.6.2 BY MODALITY,

7.3.2.6.2.1 BENCHTOP

7.3.2.6.2.2 PORTABLE

7.3.2.7 OTHERS

7.3.3 REAGENTS & CONSUMABLES

7.3.3.1 KITS

7.3.3.1.1 PCR KITS

7.3.3.1.2 RAPID TEST KITS

7.3.3.1.3 MULTIPLEX KITS

7.3.3.1.4 ELISA KITS

7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS

7.3.3.1.6 OTHERS

7.3.3.2 REAGENTS

7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS

7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS

7.3.3.2.3 COOMBS REAGENTS

7.3.3.2.4 OTHERS REAGENTS

7.3.4 MEDIA

7.3.5 PANEL

7.3.6 STRIPS

7.3.7 CASSETTE

7.3.8 CONTROL STANDARDS

7.3.9 PROBES AND PRIMER

7.3.10 OTHERS CONSUMABLE AND ACCESSORIES

8 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BACTERIAL DISEASES

8.2.1 PRODUCTION ANIMALS

8.2.2 COMPANION ANIMALS

8.3 CANINE ATOPIC DERMATITIS

8.3.1 COMPANION ANIMALS

8.3.2 PRODUCTION ANIMALS

8.4 HEMINTHES INFECTION

8.4.1 PRODUCTION ANIMALS

8.4.2 COMPANION ANIMALS

8.5 ANIMAL CANCER

8.5.1 COMPANION ANIMALS

8.5.2 PRODUCTION ANIMALS

8.6 FOOT AND MOUTH DISEASE

8.6.1 PRODUCTION ANIMALS

8.6.2 COMPANION ANIMALS

8.7 AUTOIMMUNE DISEASES

8.7.1 COMPANION ANIMALS

8.7.2 PRODUCTION ANIMALS

8.8 BLUETONGUE

8.8.1 PRODUCTION ANIMALS

8.8.2 COMPANION ANIMALS

8.9 OTHERS

8.9.1 COMPANION ANIMALS

8.9.2 PRODUCTION ANIMAL

9 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

9.1 OVERVIEW

9.2 COMPANION ANIMALS

9.2.1 DOGS

9.2.2 CATS

9.2.3 HORSES

9.2.4 OTHERS

9.3 PRODUCTION ANIMAL

9.3.1 POULTRY

9.3.2 CATTLE

9.3.3 SWINE

9.3.4 FISH

9.3.5 SHEEP & GOATS

9.3.6 OTHERS

10 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 RETAIL SALES

10.2.1 OFFLINE

10.2.1.1 HOSPITAL PHARMACY

10.2.1.2 RETAIL PHARMACY

10.2.2 ONLINE

10.2.2.1 E-COMMERCE PLATFORMS

10.2.2.2 COMPANY WEBSITE

10.2.2.3 OTHERS

10.3 DIRECT TENDER

10.4 OTHERS

11 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY END USER

11.1 OVERVIEW

11.2 VETERINARY HOSPITALS

11.2.1 PRIVATE

11.2.2 PUBLIC

11.2.3 VETERINARY HOSPITALS BY LEVEL

11.2.3.1 TIER 2

11.2.3.2 TIER 1

11.2.3.3 TIER 3

11.3 VETERINARY CLINICS

11.3.1 VETERINARY CLINICS BY TYPE

11.3.1.1 PUBLIC

11.3.1.2 PRIVATE

11.4 ANIMAL AND VETERINARY FARMS

11.5 REFERENCE LABORATORIES

11.6 ACADEMIC AND RESEARCH INSTITUTE

11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING

11.8 OTHERS

12 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY REGION

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 SAUDI ARABIA

12.1.3 U.A.E

12.1.4 EGYPT

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ZOETIS SERVICES LLC SERVICES LLC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 MERCK KGAA

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENT

15.5 IDEXX LABORATORIES, INC

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 AB SCIENCE

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 ADVACARE PHARMA

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 ALMAX IMAGING SRL

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 ANIVIVE

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BIOMÉRIEUX

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 BIONOTE USA INC.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 BIO-RAD LABORATORIES, INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 CANON MEDICAL SYSTEMS EUROPE B.V.

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENT

15.14 CARGIL INCORPORATED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 CEVA

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 CURELAB ONCOLOGY

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 DECHRA PHARMACEUTICALS LIMITED

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 DEMEDITEC DIAGNOSTICS GMBH

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 DHN

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 DIAGNOSTIC IMAGING SYSTEMS

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

15.21 ESAOTE SPA

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 EUROFINS SCIENTIFIC

15.22.1 COMPANY SNAPSHOT

15.22.2 REVENUE ANALYSIS

15.22.3 PRODUCT PORTFOLIO

15.22.4 RECENT DEVELOPMENT

15.23 EVONIK ANIMAL NUTRITION

15.23.1 COMPANY SNAPSHOT

15.23.2 REVENUE ANALYSIS

15.23.3 1.1.3 PRODUCT PORTFOLIO

15.23.4 RECENT DEVELOPMENT

15.24 FUJIFILM HOLDINGS CORPORATION

15.24.1 COMPANY SNAPSHOT

15.24.2 REVENUE ANALYSIS

15.24.3 PRODUCT PORTFOLIO

15.24.4 RECENT DEVELOPMENT

15.25 GOLD STANDARD DIAGNOSTICS

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENT

15.26 HALLMARQ VETERINARY IMAGING

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENT

15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD.

15.27.1 COMPANY SNAPSHOT

15.27.2 PRODUCT PORTFOLIO

15.27.3 RECENT DEVELOPMENT

15.28 IBIS S.R.L.

15.28.1 COMPANY SNAPSHOT

15.28.2 PRODUCT PORTFOLIO

15.28.3 RECENT DEVELOPMENT

15.29 VIRBAC

15.29.1 COMPANY SNAPSHOT

15.29.2 REVENUE ANALYSIS

15.29.3 PRODUCT PORTFOLIO

15.29.4 RECENT DEVELOPMENT

15.3 VMRD, INC

15.30.1 COMPANY SNAPSHOT

15.30.2 PRODUCT PORTFOLIO

15.30.3 RECENT DEVELOPMENT

15.31 HESKA CORPORATION

15.31.1 COMPANY SNAPSHOT

15.31.2 REVENUE ANALYSIS

15.31.3 PRODUCT PORTFOLIO

15.31.4 RECENT DEVELOPMENT

15.32 KARYOPHARM

15.32.1 COMPANY SNAPSHOT

15.32.2 REVENUE ANALYSIS

15.32.3 PRODUCT PORTFOLIO

15.32.4 RECENT DEVELOPMENT

15.33 MERIDIAN BIOSCIENCE, INC

15.33.1 COMPANY SNAPSHOT

15.33.2 PRODUCT PORTFOLIO

15.33.3 RECENT DEVELOPMENT

15.34 NARANG MEDICAL LIMITED

15.34.1 COMPANY SNAPSHOT

15.34.2 PRODUCT PORTFOLIO

15.34.3 RECENT DEVELOPMENT

15.35 NEOGEN CORPORATION

15.35.1 COMPANY SNAPSHOT

15.35.2 REVENUE ANALYSIS

15.35.3 PRODUCT PORTFOLIO

15.35.4 RECENT DEVELOPMENT

15.36 NIPPON ZENYAKU KOGYO CO., LTD.

15.36.1 COMPANY SNAPSHOT

15.36.2 PRODUCT PORTFOLIO

15.36.3 RECENT DEVELOPMENT

15.37 VETDC

15.37.1 COMPANY SNAPSHOT

15.37.2 PRODUCT PORTFOLIO

15.37.3 RECENT DEVELOPMENT

15.38 NOVAVIVE INC.

15.38.1 COMPANY SNAPSHOT

15.38.2 PRODUCT PORTFOLIO

15.38.3 RECENT DEVELOPMENT

15.39 NUTRECO

15.39.1 COMPANY SNAPSHOT

15.39.2 PRODUCT PORTFOLIO

15.39.3 RECENT DEVELOPMENT

15.4 PLANMECA OY

15.40.1 COMPANY SNAPSHOT

15.40.2 PRODUCT PORTFOLIO

15.40.3 RECENT DEVELOPMENT

15.41 RANDOX LABORATORIES LTD.

15.41.1 COMPANY SNAPSHOT

15.41.2 PRODUCT PORTFOLIO

15.41.3 RECENT DEVELOPMENT

15.42 RINGPU BIOLOGY CO., LTD.

15.42.1 COMPANY SNAPSHOT

15.42.2 PRODUCT PORTFOLIO

15.42.3 RECENT DEVELOPMENT

15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD

15.43.1 COMPANY SNAPSHOT

15.43.2 PRODUCT PORTFOLIO

15.43.3 RECENT DEVELOPMENT

15.44 THERMO FISHER SCIENTIFIC INC

15.44.1 COMPANY SNAPSHOT

15.44.2 REVENUE ANALYSIS

15.44.3 PRODUCT PORTFOLIO

15.44.4 RECENT DEVELOPMENT

15.45 TORIGEN PHARMACEUTICALS INC.

15.45.1 COMPANY SNAPSHOT

15.45.2 PRODUCT PORTFOLIO

15.45.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

Tabellenverzeichnis

TABLE 1 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 2 MIDDLE EAST AND AFRICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 3 MIDDLE EAST AND AFRICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA AANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 11 MIDDLE EAST AND AFRICA HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA KAPPA AGONIST MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018 2032 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018 2032 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018 2032 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 20 MIDDLE EAST AND AFRICA PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 21 MIDDLE EAST AND AFRICA VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 22 MIDDLE EAST AND AFRICA BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 23 MIDDLE EAST AND AFRICA MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 24 MIDDLE EAST AND AFRICA MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 25 MIDDLE EAST AND AFRICA ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 26 MIDDLE EAST AND AFRICA AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 27 MIDDLE EAST AND AFRICA VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 28 MIDDLE EAST AND AFRICA FAT SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 29 MIDDLE EAST AND AFRICA WATER SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 30 MIDDLE EAST AND AFRICA ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 31 MIDDLE EAST AND AFRICA PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 32 MIDDLE EAST AND AFRICA FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 33 MIDDLE EAST AND AFRICA MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 34 MIDDLE EAST AND AFRICA MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 35 MIDDLE EAST AND AFRICA PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 36 MIDDLE EAST AND AFRICA CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 37 MIDDLE EAST AND AFRICA TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 38 MIDDLE EAST AND AFRICA PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 39 MIDDLE EAST AND AFRICA FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 40 MIDDLE EAST AND AFRICA SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 41 MIDDLE EAST AND AFRICA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 42 MIDDLE EAST AND AFRICA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 43 MIDDLE EAST AND AFRICA INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 44 MIDDLE EAST AND AFRICA IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 45 MIDDLE EAST AND AFRICA X RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 46 MIDDLE EAST AND AFRICA ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 47 MIDDLE EAST AND AFRICA COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 48 MIDDLE EAST AND AFRICA MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 49 MIDDLE EAST AND AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 50 MIDDLE EAST AND AFRICA LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 52 MIDDLE EAST AND AFRICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018 2032 (USD THOUSAND)

TABLE 53 MIDDLE EAST AND AFRICA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 54 MIDDLE EAST AND AFRICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 55 MIDDLE EAST AND AFRICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 56 MIDDLE EAST AND AFRICA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 57 MIDDLE EAST AND AFRICA POINT OF CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 58 MIDDLE EAST AND AFRICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 59 MIDDLE EAST AND AFRICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 60 MIDDLE EAST AND AFRICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018 2032 (USD THOUSAND)

TABLE 61 MIDDLE EAST AND AFRICA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 62 MIDDLE EAST AND AFRICA URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018 2032 (USD THOUSAND)

TABLE 63 MIDDLE EAST AND AFRICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 64 MIDDLE EAST AND AFRICA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018 2032 (USD THOUSAND)

TABLE 65 MIDDLE EAST AND AFRICA REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 66 MIDDLE EAST AND AFRICA KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 67 MIDDLE EAST AND AFRICA REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 68 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY APPLICATION, 2018 2032 (USD THOUSAND)

TABLE 69 MIDDLE EAST AND AFRICA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 70 MIDDLE EAST AND AFRICA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 71 MIDDLE EAST AND AFRICA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 72 MIDDLE EAST AND AFRICA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 73 MIDDLE EAST AND AFRICA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 74 MIDDLE EAST AND AFRICA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 75 MIDDLE EAST AND AFRICA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 76 MIDDLE EAST AND AFRICA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 77 MIDDLE EAST AND AFRICA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 78 MIDDLE EAST AND AFRICA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 79 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 80 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 81 MIDDLE EAST AND AFRICA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 82 MIDDLE EAST AND AFRICA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 83 MIDDLE EAST AND AFRICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 84 MIDDLE EAST AND AFRICA OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 85 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018 2032 (USD THOUSAND)

TABLE 86 MIDDLE EAST AND AFRICA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 87 MIDDLE EAST AND AFRICA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 88 MIDDLE EAST AND AFRICA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 89 MIDDLE EAST AND AFRICA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 90 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018 2032 (USD THOUSAND)

TABLE 91 MIDDLE EAST AND AFRICA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 92 MIDDLE EAST AND AFRICA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 93 MIDDLE EAST AND AFRICA OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 94 MIDDLE EAST AND AFRICA ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 95 MIDDLE EAST AND AFRICA DIRECT TENDER IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 96 MIDDLE EAST AND AFRICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 97 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY END USER, 2018 2032 (USD THOUSAND)

TABLE 98 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 99 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 100 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018 2032 (USD THOUSAND)

TABLE 101 MIDDLE EAST AND AFRICA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 102 MIDDLE EAST AND AFRICA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 103 MIDDLE EAST AND AFRICA ANIMAL AND VETERINARY FARMS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 104 MIDDLE EAST AND AFRICA REFERENCE LABORATORIES IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 105 MIDDLE EAST AND AFRICA ACADEMIC AND RESEARCH INSTITUTE IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 106 MIDDLE EAST AND AFRICA POINT OF CARE TESTING/IN HOUSE TESTING IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 107 MIDDLE EAST AND AFRICA OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018 2032 (USD THOUSAND)

TABLE 1 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY COUNTRY, 2018 2032 (USD THOUSAND)

TABLE 2 MIDDLE EAST AND AFRICA VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 3 MIDDLE EAST AND AFRICA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA ANALGESICS/ANTI INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018 2032 (USD THOUSAND)